K192667 is an FDA 510(k) clearance for the gel-e Flex+ gel OTC. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).
Submitted by Gel-E, Inc. (College Park, US). The FDA issued a Cleared decision on October 25, 2019 after a review of 30 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Gel-E, Inc. devices